Welcome to the Karanicolas lab

 
 

Our goal is to develop structure-based approaches for modulating protein function using small-molecules. We apply these new approaches in projects seeking to re-activate disabled tumor suppressors, inhibit cancer-driving RNA-binding proteins, disable key oncogenic kinases, and tune activity of antibodies used in cancer immunotherapy.

Harnessing the power of computational chemical biology to address non-traditional drug targets